Getinge Dirección

Dirección controles de criterios 3/4

El CEO de Getinge's es Mattias Perjos , nombrado en Mar 2017, tiene una permanencia de 7.08 años. compensación anual total es SEK46.39M, compuesta por 55.9% salario y 44.1% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.029% de las acciones de la empresa, por valor de €1.60M. La antigüedad media del equipo directivo y de la junta directiva es de 4.5 años y 7.1 años, respectivamente.

Información clave

Mattias Perjos

Chief Executive Officer (CEO)

kr46.4m

Compensación total

Porcentaje del salario del CEO	55.9%
Permanencia del CEO	7.3yrs
Participación del CEO	0.03%
Permanencia media de la dirección	4.6yrs
Promedio de permanencia en la Junta Directiva	7.3yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Mattias Perjos en comparación con los beneficios de Getinge?
Fecha	Compensación total	Salario	Ingresos de la empresa
Mar 31 2024	n/a	n/a	kr2b
Dec 31 2023	kr46m	kr26m	kr2b
Sep 30 2023	n/a	n/a	kr2b
Jun 30 2023	n/a	n/a	kr2b
Mar 31 2023	n/a	n/a	kr3b
Dec 31 2022	kr43m	kr24m	kr2b
Sep 30 2022	n/a	n/a	kr3b
Jun 30 2022	n/a	n/a	kr3b
Mar 31 2022	n/a	n/a	kr3b
Dec 31 2021	kr60m	kr23m	kr3b
Sep 30 2021	n/a	n/a	kr3b
Jun 30 2021	n/a	n/a	kr4b
Mar 31 2021	n/a	n/a	kr4b
Dec 31 2020	kr67m	kr23m	kr3b
Sep 30 2020	n/a	n/a	kr3b
Jun 30 2020	n/a	n/a	kr2b
Mar 31 2020	n/a	n/a	kr1b
Dec 31 2019	kr46m	kr22m	kr1b
Sep 30 2019	n/a	n/a	kr1b
Jun 30 2019	n/a	n/a	-kr632m
Mar 31 2019	n/a	n/a	-kr654m
Dec 31 2018	kr34m	kr21m	-kr967m
Sep 30 2018	n/a	n/a	-kr727m
Jun 30 2018	n/a	n/a	kr847m
Mar 31 2018	n/a	n/a	kr676m
Dec 31 2017	kr26m	kr15m	kr1b

Compensación vs. Mercado: La compensación total de Mattias($USD4.37M) está por encima de la media de empresas de tamaño similar en el mercado German ($USD3.12M).

Compensación vs. Ingresos: La compensación de Mattias ha sido consistente con los resultados de la empresa en el último año.

CEO

Mattias Perjos (52 yo)

7.3yrs

Permanencia

kr46,388,000

Compensación

Mr. Mattias Perjos, M. Sc., serves as Independent Director at Euroapi S. A. since January 11, 2023. He has been the Chief Executive Officer and President at Getinge AB since March 27, 2017. Mr. Perjos serv...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Mattias Perjos	CEO, President & Director	7.3yrs	kr46.39m	0.029% SEK 1.3m
Agneta Palmer	Chief Financial Officer	less than a year	sin datos	sin datos
Lars Mattsson	Head of Investor Relations	no data	sin datos	sin datos
Anna Romberg	Executive Vice President of Sustainability	3.7yrs	sin datos	0.0020% SEK 91.2k
Magnus Lundback	Executive Vice President of Human Resources	7.4yrs	sin datos	0.0014% SEK 63.6k
Carsten Blecker	Chief Commercial Officer	6.5yrs	sin datos	0.0018% SEK 83.0k
Stephane Roy	President of Surgical Workflows	5.6yrs	sin datos	0.0014% SEK 63.2k
Eric Honroth	President of Life Science	no data	sin datos	0.000060% SEK 2.7k
Patricia Fitch	President of North America Region	2.2yrs	sin datos	sin datos
Elin Frostehav	President of Acute Care Therapies	2.2yrs	sin datos	0.00032% SEK 14.4k
Joanna Engelke	Executive VP of Quality Compliance	1.7yrs	sin datos	sin datos
Avril Forde	President of Maquet Ltd & Maquet Ireland	8.4yrs	sin datos	sin datos

4.6yrs

Permanencia media

52yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de GTN se considera experimentado (4.5 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Mattias Perjos	CEO, President & Director	7.3yrs	kr46.39m	0.029% SEK 1.3m
Johan Bygge	Independent Director	17.2yrs	kr972.90k	0.0058% SEK 260.0k
Carl Bennet	Non-Independent Vice Chairman	35.4yrs	kr781.43k	sin datos
Malin Persson	Independent Director	10.4yrs	kr781.43k	0.0030% SEK 134.5k
Johan Malmquist	Independent Chairman	8.3yrs	kr1.73m	0.037% SEK 1.7m
Cecilia Wennborg	Independent Director	14.2yrs	kr969.80k	0.0029% SEK 132.7k
Ake Larsson	Employee Representative Director	1.7yrs	sin datos	sin datos
Dan Frohm	Non-Independent Director	7.3yrs	kr928.40k	0.055% SEK 2.5m
Fredrik Brattborn	Employee Representative Director	2.2yrs	sin datos	sin datos
Kristian Samuelsson	Independent Director	3.2yrs	kr819.72k	sin datos
Pontus Kall	Deputy Director	no data	sin datos	sin datos
Ida Gustafsson	Deputy Director	1.7yrs	sin datos	0.000020% SEK 902.6

7.3yrs

Permanencia media

54yo

Promedio de edad

Junta con experiencia: La junta directiva de GTN se considera experimentada (7.1 años de antigüedad promedio).

Getinge Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

Getinge Announces CFO Changes

Getinge AB (Publ) Announces Resignation of Jeanette Hedén Carlsson as Executive Vice President Brand & Communication, Effective December 31, 2023

Getinge AB (Publ) Announces Executive Changes

Getinge AB (Publ) Appoints Joanna Engelke as New Executive Vice President Quality Compliance, Regulatory & Medical Affairs and Member of the Getinge Executive Team

Getinge Appoints Agneta Palmér as Executive Vice President Operational Services Member of the Getinge Executive Team

Lena Hagman to Leave Getinge AB (publ) as Executive Vice President Quality Compliance, Regulatory & Medical Affairs

Recent updates

Investor sentiment deteriorates as stock falls 17%

Getinge AB (publ) Declares A Dividend, Payable on 29 April 2024

Upcoming dividend of kr4.40 per share

Full year 2023 earnings released: EPS: kr8.86 (vs kr9.15 in FY 2022)

Getinge AB (publ) to Report Fiscal Year 2024 Results on Jan 28, 2025

Dividend of kr4.40 announced

Getinge AB (publ) to Report Fiscal Year 2023 Final Results on Mar 27, 2024

Getinge AB (Publ) Proposes Dividend, Payable on April 29, 2024

Getinge Takes A Leap Forward in Cardiovascular Surgery with the 510(k) Clearance for Vasoview Hemopro 3

Full year 2023 earnings released: EPS: kr8.86 (vs kr9.15 in FY 2022)

Getinge AB (Publ) Provides Sales Guidance for the Year 2024

Getinge Announces CFO Changes

Third quarter 2023 earnings released

Getinge AB (publ) (OM:GETI B) acquired Healthmark Industries Company, Inc. for $320 million.

Getinge AB (Publ) Announces Resignation of Jeanette Hedén Carlsson as Executive Vice President Brand & Communication, Effective December 31, 2023

Second quarter 2023 earnings released

Getinge Receives US FDA 510(K) Clearance for Servo-Air® Lite

Investor sentiment deteriorates as stock falls 16%

Getinge AB (publ) (OM:GETI B) entered into an agreement to acquire High Purity New England Inc. for approximately $290 million.

First quarter 2023 earnings released

Now 23% undervalued

Upcoming dividend of kr4.25 per share at 1.6% yield

Getinge Provides Financial Guidance for the First Half, Second Half and Full Year of 2023

Full year 2022 earnings released: EPS: kr9.15 (vs kr10.90 in FY 2021)

Getinge AB (Publ) Proposes Dividend

U.S. Food and Drug Administration Broadens the Consent Decree with Getinge and Includes Its Subsidiary Datascope

Third quarter 2022 earnings released

Getinge AB (publ) Provides Sales Guidance for the Full Year 2022

Getinge AB (Publ) Announces Executive Changes

Getinge AB (Publ) Appoints Joanna Engelke as New Executive Vice President Quality Compliance, Regulatory & Medical Affairs and Member of the Getinge Executive Team

Second quarter 2022 earnings released: EPS: kr2.21 (vs kr2.93 in 2Q 2021)

Getinge AB (Publ) Announces Medical Device Field Action of Hls Set Advanced Products

Getinge Appoints Agneta Palmér as Executive Vice President Operational Services Member of the Getinge Executive Team

Getinge AB (publ) to Report Q2, 2022 Results on Jul 19, 2022

Lena Hagman to Leave Getinge AB (publ) as Executive Vice President Quality Compliance, Regulatory & Medical Affairs

Investor sentiment deteriorated over the past week

Getinge Revises Net Sales Guidance for the Full Year 2022

Independent Chairman recently bought €281k worth of stock

Insufficient new directors

Getinge AB (publ) Declares Dividend for 2021, Payable on May 3, 2022

Upcoming dividend of kr4.00 per share

Getinge AB (publ) to Report Q1, 2022 Results on Apr 26, 2022

Full year 2021 earnings released: EPS: kr10.90 (vs kr11.89 in FY 2020)

Insufficient new directors

Getinge AB to Report Q4, 2022 Results on Feb 01, 2023

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Getinge AB to Report Q4, 2022 Results on Feb 01, 2023

Getinge AB (OM:GETI B) acquired Talis Clinical, LLC for approximately SEK 600 million.

Chief Commercial Officer recently bought €56k worth of stock

Third quarter 2021 earnings released

Second quarter 2021 earnings released: EPS kr2.93 (vs kr1.81 in 2Q 2020)

Getinge AB Provides Sales Guidance for the Year 2021

Getinge's New Torin Artificial Intelligence Solution Improves Hospital Efficiency

Chief Commercial Officer recently bought €27k worth of stock

Chief Commercial Officer recently bought €27k worth of stock

First quarter 2021 earnings released: EPS kr2.36 (vs kr0.99 in 1Q 2020)

Director has left the company

Upcoming dividend of kr3.00 per share

Full year 2020 earnings released: EPS kr11.89 (vs kr4.49 in FY 2019)

Getinge AB Proposes Dividend, Payable on April 27, 2021

Getinge AB and University of Gothenburg Initiates Strategic Research Partnership

New 90-day high: €22.23

Getinge AB Proposes Executive Changes

Full year 2020 earnings released: EPS kr11.89 (vs kr4.49 in FY 2019)

Revenue misses expectations

New 90-day high: €19.57

Getinge Is Announcing A Recall of HLS Set Advanced Products

Getinge AB Provides No Guidance for the Fourth Quarter of 2020 and for Year 2021

Getinge Not to Present Outlook for the Full Year 2020